Bone marrow histology and CD34 immunostaining in the prognostic evaluation of primary myelodysplastic syndromes

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 360-364

  Oriani, A ^a   Annaloro, C ^a   Soligo, D ^a   Pozzoli, E ^a   Cortelezzi, A ^a   Lambertenghi Deliliers, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone marrow biopsy; CD34 immunostaining; Histology; Myelodysplastic syndromes

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKEMIA; MAJOR CLINICAL STUDY; MYELODYSPLASIA; PRIORITY JOURNAL;

EID: 0030049946     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1484.x     Document Type: Article

References (32)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, U.R. & Sultan, C. (1982) The French-American-British cooperative group: proposals for the classification of myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Beris, P. (1989) Primary clonal myelodysplastic syndromes. Seminars in Hematology, 26, 216-235.
3. Civin, C.I., Banquerigo, M.L., Strauss, L.C. & Loken, M.R. (1987) Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Experimental Hematology, 15, 10-17.
4. Coiffier, B., Adeleine, P., Gentilhomme, O., Felman, P., Treille-Ritouet, D. & Bryon, P.A. (1987) Myelodysplastic syndromes: a multiparametric study of prognostic factors in 336 patients. Cancer, 60, 3029-3032.
5. Cordell, J.L., Falini, B., Erber, W.N., Ghoshak, A.K., Zainalabidden, A., MacDonald, S., Pulford, K.A.F., Stein, H. & Mason, D.Y. (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti alkaline phosphatase (APAAP) complexes. Journal of Histochemistry and Cytochemistry, 32, 219-229.
6. Delacretaz, F., Schmidt, P.M., Pignet, D., Bachmann, F. & Costa, J. (1987) Histopathology of myelodysplastic syndromes. American Journal of Clinical Pathology, 87, 180-186.
7. Frisch, B., Lewis, S.M., Burkhardt, R. & Bartl, R. (1985) Acute leukemias and myelodysplasias. Biopsy Pathology of Bone and Bone Marrow, pp. 157-160. Raven Press, New York.
8. Goasguen, J.E., Garand, R., Bizet, M., Bremond, J.L., Gardais, J., Callat, M.P., Accard, F. & Caperon, J. (1990) Prognostic factors of myelodysplastic syndromes: a simplified 3-D scoring system. Leukemia Research, 14, 255-262.
9. Guyotat, U., Campos, L., Thomas, X., Vila, L., Shi, Z., Charrin, C., Gentilhomme, O. & Fiere, D. (1990) Myelodysplastic syndromes: a study of surface markers and in vitro growth patterns. American Journal of Hematology, 34, 26-31.
10. Hamblin, T.J. & Oscier, D.G. (1987) The myelodysplastic syndrome: a practical guide. Hematoloaical Oncology, 5, 19-34.
11. Hasle, H. (1994) Myelodysplastic syndromes in childhood: classification, epidemiology, and treatment. Leukemia and Lymphoma, 13, 11-26.
12. Jacobs, R.H., Cornbleet, M.A., Vardiman, J.W., Larson, R.A., Le Beau, M.M. & Rowley, J.D. (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood, 67, 1768-1772.
13. Kitagawa, M., Kamiyama, R., Takemura, T. & Kasuga, T. (1989) Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Archiv: B: Cell Pathology, 57, 47-53.
14. Lambertenghi Deliliers, G., Annaloro, C., Oriani, A., Soligo, D., Pozzoli, E. & Poll,. E.E. (1993) Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Annals of Hematology, 66, 85-91.
15. Lambertenghi-Deliliers, G., Soligo, D., Annaloro, C., Pozzoli, E. & Riva, A. (1992) Bone marrow biopsy in RAEB and RAEB-t myelodysplastic syndromes. Myelodysplastic Syndromes (ed. by F. Schmalzl and G. J. Mufti), pp. 67-73. Springer, Berlin.
16. Mahalanobis, P.C. (1936) On the generalized distance in statistics. Proceedings of the National Institute of Science (India), 2, 49-55.
17. Mangi, M.H. & Mufti. G.J. (1992) Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsy. Blood, 79, 198-205.
18. Mangi, M.H., Salisbury, J.R. & Mufti, G.J. (1991) Abnormal localization of immature precursors (ALIP) in the bone marrow of myelodysplastic syndromes: current state of knowledge and future directions. Leukemia Research, 5, 627-639.
19. Manoharan, A., Horsley, R. & Pitney, W.R. (1979) The reticulin content of bone marrow in acute leukaemia in adults. British Journal of Haematology, 43, 185-190.
20. Mufti, G.J. (1992) A guide to risk assessment in the primary myelodysplastic syndrome. Hematology/Oncology Clinics of North America, 6, 587-606.
21. Mufti, G.J., Stevens, H., Jr. Oscier, D.G., Hamblin, T.J. & Machin, D. (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. British Journal of Haematology, 59, 425-453.
22. Oertel, J., Kleiner, S. & Huhn, D. (1993) Immunotyping of blasts in refractory anaemia with excess of blasts. British Journal of Haematology, 84, 305-309.
23. Sanz, G.F. & Sanz, M.A. (1992) Prognostic factors in myelodysplastic syndromes. Leukemia Research, 16, 77-86.
24. Sanz, G.F., Sanz, M.A., Vallespi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395-408.
25. + cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia, 5, 1026-1030.
26. Soligo, D.A., Oriani, A., Annaloro, C., Cortelezzi, A., Calori, R., Pozzoli, P., Nosella, D., Orazi, A. & Lambertenghi Deliliers, G. (1994) CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes. American Journal of Hematology, 46, 9-17.
27. + cells: an adverse prognostic factor in the myelodysplastic syndromes. American Journal of Hematology, 39, 96-101.
28. Thiele, J., Arenz, B., Klein, H., Vierbuchen, M., Zancovich, R. & Fischer, R. (1988) Differentiation of plasma cell infiltrates in the bone marrow: a clinico-pathological study on 80 patients including immunohistochemistry and morphometry. Virchows Archiv: A: Pathological Anatomy and Histopathohgy, 412, 553-562.
29. Third MIC Cooperative Study Group (1988) Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genetics and Cytogenetics, 32, 1-10.
30. Tricot, G., De Wolf-Peeters, C., Hendrickx, B. & Verwilghen, R.L. (1984a) Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. British Journal of Haematology, 57, 423-430.
31. Tricot, G., De Wolf-Peeters, C., Vlietinck, R. & Verwilghen, R.L. (1984b) Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. British Journal of Haematology, 58, 217-225.
32. Tricot, G., Vlietinck, R., Boogaerts, M.A., Hendrickx, B., De Wolf-Peeters, C., Van den Berghe, H. & Verwilghen, R.L. (1985) Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. British Journal of Haematology, 60, 19-32.